carmustine has been researched along with Brain Stem Neoplasms in 1 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Brain Stem Neoplasms: Benign and malignant intra-axial tumors of the MESENCEPHALON; PONS; or MEDULLA OBLONGATA of the BRAIN STEM. Primary and metastatic neoplasms may occur in this location. Clinical features include ATAXIA, cranial neuropathies (see CRANIAL NERVE DISEASES), NAUSEA, hemiparesis (see HEMIPLEGIA), and quadriparesis. Primary brain stem neoplasms are more frequent in children. Histologic subtypes include GLIOMA; HEMANGIOBLASTOMA; GANGLIOGLIOMA; and EPENDYMOMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sewing, AC | 1 |
| Caretti, V | 1 |
| Lagerweij, T | 1 |
| Schellen, P | 1 |
| Jansen, MH | 1 |
| van Vuurden, DG | 1 |
| Idema, S | 1 |
| Molthoff, CF | 1 |
| Vandertop, WP | 1 |
| Kaspers, GJ | 1 |
| Noske, DP | 1 |
| Hulleman, E | 1 |
1 other study available for carmustine and Brain Stem Neoplasms
| Article | Year |
|---|---|
Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.
Topics: Animals; Antineoplastic Agents; Brain Stem; Brain Stem Neoplasms; Carmustine; Catheters; Convection; | 2014 |